arginine vasopressin has been researched along with Albuminuria in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alhenc-Gelas, F; Bankir, L; Bellili-Munoz, N; Bouby, N; Fumeron, F; Hadjadj, S; Marre, M; Matallah, N; Mohammedi, K; Potier, L; Roussel, R; Taveau, C; Velho, G | 1 |
| de Jong, PE; Gansevoort, RT; Meijer, E | 1 |
| Kutina, AV; Natochin, YV; Shakhmatova, EI | 1 |
| Bankir, L; Bouby, N; Enhörning, S; Hedblad, B; Melander, O; Morgenthaler, NG; Nilsson, PM; Persson, M; Struck, J | 1 |
| Christensen, PD; Christiansen, JS; Hansen, KW; Mogensen, CE; Pedersen, EB; Sørensen, K | 1 |
| Iizuka, T; Nishikawa, T; Omura, M; Saito, I; Yoshida, S | 1 |
| Cignarelli, M; Coratelli, P; Cospite, R; De Pergola, G; Giorgino, R; Narelli, GM; Passavanti, G; Paternostro, A; Romanazzi, V | 1 |
1 trial(s) available for arginine vasopressin and Albuminuria
| Article | Year |
|---|---|
Short-term clinical trial of 1-(1-[4-(3-acetylaminopropoxy)-benzoyl]-4-piperidyl)-3, 4-dihydro-2(1H)-quinolinone in patients with diabetic nephropathy. Possible effectiveness of the specific vasopressin V1 receptor antagonist for reducing albuminuria in p
Topics: Albuminuria; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Blood Glucose; Blood Pressure; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Heart Rate; Humans; Male; Middle Aged; Piperidines; Quinolones; Saline Solution, Hypertonic | 1996 |
6 other study(ies) available for arginine vasopressin and Albuminuria
| Article | Year |
|---|---|
Plasma copeptin and renal outcomes in patients with type 2 diabetes and albuminuria.
Topics: Aged; Albuminuria; Arginine Vasopressin; Biomarkers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Glycopeptides; Humans; Kidney Failure, Chronic; Kidney Function Tests; Male; Middle Aged | 2013 |
Vasopressin and microalbuminuria: is it vasopressin per se or is it salt intake?
Topics: Albuminuria; Arginine Vasopressin; Feeding Behavior; Female; Humans; Male; Vasopressins | 2010 |
Effect of a blocker of nitric oxide production on albumin excretion by rat kidney.
Topics: Albumins; Albuminuria; Animals; Arginine Vasopressin; Enzyme Inhibitors; Female; Kidney; Kidney Glomerulus; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Proteinuria; Rats; Rats, Wistar; Vasotocin | 2011 |
Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: the prospective Malmö Diet and Cancer Study cardiovascular cohort.
Topics: Age Distribution; Age of Onset; Aged; Aged, 80 and over; Albuminuria; Arginine Vasopressin; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Diabetes Mellitus; Female; Glycopeptides; Humans; Longitudinal Studies; Male; Metabolic Syndrome; Middle Aged; Neoplasms; Obesity, Abdominal; Predictive Value of Tests; Prevalence; Prospective Studies; Risk Factors; Sex Distribution; Sweden; Time Factors | 2013 |
Night blood pressure: relation to organ lesions in microalbuminuric type 1 diabetic patients.
Topics: Adult; Albuminuria; Aldosterone; Arginine Vasopressin; Blood Pressure; Body Mass Index; Circadian Rhythm; Diabetes Mellitus, Type 1; Diastole; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged; Potassium; Sodium; Systole | 1995 |
Renal excretion of arginine-vasopressin in microalbuminuric diabetic patients.
Topics: Aged; Albuminuria; Arginine Vasopressin; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Osmolar Concentration; Potassium; Sodium | 1989 |